Operant Conditioning for Foot Drop Post-Stroke
Trial Summary
What is the purpose of this trial?
This trial helps stroke survivors with foot drop improve their muscle control. The study focuses on people who have ongoing muscle weakness in their legs after a stroke. By practicing specific movements and getting feedback, participants can learn to better control their muscles.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators.
What data supports the effectiveness of the treatment Operant conditioning for Foot Drop Post-Stroke?
Research shows that operant conditioning, which involves rewarding desired behaviors, has been effective in improving motor abilities and functional independence in stroke patients by overcoming learned nonuse (a condition where patients stop using an affected limb). Additionally, combining operant conditioning with physiotherapy has helped individuals with movement difficulties learn necessary skills, suggesting it could be beneficial for foot drop post-stroke.12345
Is operant conditioning therapy safe for humans?
How is operant conditioning treatment different from other treatments for foot drop post-stroke?
Operant conditioning treatment is unique because it uses a learning-based approach to gradually change spinal reflexes, helping to restore movement skills by encouraging the nervous system to adapt and reorganize itself, unlike traditional therapies that may focus more on physical exercises or medication.138910
Research Team
Eligibility Criteria
This trial is for adults over 18 who had a stroke at least 6 months ago, resulting in hemiparesis and foot drop. Participants must be able to see computer icons from 4 feet away, follow verbal instructions, walk with or without help despite gait issues due to weak tibialis anterior muscle.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Participants complete 6 baseline sessions to establish initial reflex pathway measurements
Treatment
Participants undergo 30 up conditioning sessions to modify reflex pathways in the paretic leg
Follow-up
Participants are monitored for changes in reflex pathways and walking ability post-treatment
Treatment Details
Interventions
- Operant conditioning (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Nevada, Las Vegas
Lead Sponsor
Dr. Albert Bourla
University of Nevada, Las Vegas
Chief Executive Officer since 2019
PhD in Molecular Biology, Harvard Medical School
Dr. Patrizia Cavazzoni
University of Nevada, Las Vegas
Chief Medical Officer
McGill University, MD